gotistibart | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

9 results for “gotistibart”

Trials

Enrolling By Invitation

Gotistobart Long Term Extension (LTE) Study

20 participants · First posted Jun 22, 2026

Active, not recruiting

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

630 participants · First posted Jan 4, 2023

Drugs

Gotistobart

News

BioNTech and Genentech Terminate Phase II autogene cevumeran Trial in Resected Colorectal Cancer After OS Imbalance Favors Control

Gotistobart Plus Pembrolizumab Shows Promise in Platinum-Resistant Ovarian Cancer

FDA Places Partial Clinical Hold on BioNTech and OncoC4's Gotistobart Phase III NSCLC Trial